drugset / Trial / NCT04407078
Sugammadex on Remifentanil Ce for Preventing Emergence Cough in Female
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to investigate the optimal Ce of remifentanil for preventing emergence cough following extubation during general anesthesia in female who are reversed with sugammadex or neostigmine.
Timeline
- Start
- 2019-12-02
- Primary completion
- 2021-01-06
- Completion
- 2021-01-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Neostigmine | Other / unclassified | 50 ug/kg | Intravenous |
| Subject | Sugammadex | Other / unclassified | 2 mg/kg | Intravenous |
| Comparator | Glycopyrrolate | Small molecule | 10 ug/kg | Intravenous |